Aptose Biosciences's total assets for Q3 2024 were $10.93M, a decrease of -0.18% from the previous quarter. TSE:APS total liabilities were $20.06M for the fiscal quarter, a 52.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.